Concepedia

Fernando Andrés‐Pretel

FA

Statistics

Publications

11

Citations

587

H-Index

10

Active since

2009

Affiliations

University of Castilla-La Mancha(Current)

Hospital General Universitario de Albacete

Centro de Investigación Biomédica en Red de Fragilidad y Envejecimiento Saludable

Ministry of Economy, Industry and Competitiveness

Complejo Hospitalario Universitario de Albacete

Fernando Andrés‐Pretel is an author at University of Castilla-La Mancha specializing in immunology, medicine, and tumor immunology.

ORCID

Top concepts

Publications per year

2009–2021

11

Publications

11

JAK inhibition reduces SARS-CoV-2 liver infectivity and modulates inflammatory responses to reduce morbidity and mortality

Justin Stebbing, Ginés Sánchez Nievas, Marco Falcone et al. · Science Advances · 2020 · 215 citations · Full text

, , +17

Immunogenicity of the <scp>BNT162b2</scp> vaccine in frail or disabled nursing home residents: <scp>COVID‐A</scp> study

Sergio Salmerón Ríos, Marta Mas Romero, Elisa Belén Cortés Zamora et al. · Journal of the American Geriatrics Society · 2021 · 80 citations · Full text

Expression of MHC class I, HLA-A and HLA-B identifies immune-activated breast tumors with favorable outcome

María del Mar Noblejas‐López, Cristina Nieto‐Jiménez, Sara Morcillo García et al. · OncoImmunology · 2019 · 79 citations · Full text

, , +21

Synthetic Lethality Interaction Between Aurora Kinases and CHEK1 Inhibitors in Ovarian Cancer

Ana Alcaráz-Sanabria, Cristina Nieto‐Jiménez, Verónica Corrales‐Sánchez et al. · Molecular Cancer Therapeutics · 2017 · 55 citations · Full text

Functional transcriptomic annotation and protein–protein interaction network analysis identify NEK2, BIRC5, and TOP2A as potential targets in obese patients with luminal A breast cancer

Miriam Nuncia‐Cantarero, Sandra Martínez‐Canales, Fernando Andrés‐Pretel et al. · Breast Cancer Research and Treatment · 2018 · 43 citations · Full text

1–5 of 11